Used by the following OpenPrescribing measures:

• High-cost Angiotensin-Converting Enzyme (ACE) inhibitors

Used by the following OpenPrescribing measures:

• High-cost Angiotensin-II Receptor Blockers (ARBs)

Used by the following OpenPrescribing measures:

• Zuclopenthixol acetate prescribing in primary care

Used by the following OpenPrescribing measures:

• High-cost PPIs

Used by the following OpenPrescribing measures:

• Higher dose Proton Pump Inhibitors (PPIs)

Used by the following OpenPrescribing measures:

• Silver dressings

Used by the following OpenPrescribing measures:

• Glaucoma eye drops prescribed by brand

Used by the following OpenPrescribing measures:

• Environmental Impact of Inhalers

Used by the following OpenPrescribing measures:

• Nebivolol 2.5mg tablets

Used by the following OpenPrescribing measures:

• High dose opioid items as percentage regular opioids

Used by the following OpenPrescribing measures:

• Soluble/effervescent forms of paracetamol and co-codamol

Used by the following OpenPrescribing measures:

• Low and medium intensity statins

Used by the following OpenPrescribing measures:

• Prescribing of high cost tramadol preparations

Used by the following OpenPrescribing measures:

• Desogestrel prescribed as a branded product

Used by the following OpenPrescribing measures:

• Glaucoma eye drops prescribed by brand